Ever Expanding Intellectual Property Portfolio
U.S. Provisional Applications Filed to Date
U.S. Provisional Patent Applications
U.S. PCT (Non- Provisional) Patent Applications
29
19
10
Blanketing the Biosynthetic Production Space
U.S. Provisional Patent Application
63/424,567
“ Alternative Enzyme Sources”
U.S. Provisional Patent Application
63/424,563
“ In Vivo Production of 5-Methoxy-N,N-Dimethyltryptanime in Escherichia Coli”
U.S. Provisional Patent Application
63/424,527
“Optimizing the De Novo Production of Psilocybin in E. Coli ”
U.S. Provisional Patent Application
63/392,527
“NMDA Receptor Antagonists Containing Compositions and Method of Treatment”
U.S. Provisional Patent Application
63/144,044
“Psychopharmacological Interactions Between Tryptamines Present in Psilocybe Mushrooms”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2020/51543
“Methods for the Production of Psilocybin and Intermediates Thereof”
U.S. Provisional Patent Application 62/926,875 “Methods for the Production of Psilocybin”
U.S.PCT (Non- Provisional) Patent Application 62/990,633 “Methods for the Production of Psilocybin and Intermediates or Side Products
U.S.PCT (Non- Provisional) Patent Application
PCT /US2022/070094
“Psilocybin and Norbaeocystin Compositions and Methods of Treatment”
U.S. Provisional Patent Application 63/135,054 “Psychopharmacological Interactions Between Tryptamines Present in Psilocybe Mushrooms”
U.S. Provisional Patent Application 63/219,430 “Psilocybin and Norbaeocystin Compositions and Treatment Methods ”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/070132
“ System/Methods for Pharmaceutical Prod. of Psilocybin and Intermediates or Side Products”
U.S. Provisional Patent Application 63/135,864 “System/Methods for Pharmaceutical Production of Psilocybin & Intermediates”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/071797
“Optimized Methods for the Production of Psilocybin & Intermediates or Side Products”
U.S. Provisional Patent Application 63/176,590 “Optimized Methods for the Production of Psilocybin & Intermediates ”
U.S. Provisional Patent Application 63/263,611 “Optimized Methods for the Production of Psilocybin & Intermediates ”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/074579
“Methods for the Production of Methylated Tryptamine derivatives/Intermediates or Side Products”
U.S. Provisional Patent Application 63/203,970“Methods of Production Methylated Tryptami/Intermediates/Side Products ”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/079308
“Methods for Improved Prod. of Psilocybin/ Intermediates/ Side Products Enzyme optimization”
U.S. Provisional Patent Application 63/263,607 “Improved Pro. of Psilocybin/Intermediates/Side Products Enzyme optimization”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/079308
“Metabolic Engineering Methods for the Production of Psilocybin and Intermediates or Side Products”
U.S. Provisional Patent Application 63/263,614 “ Methods of Prod. Methylated Tryptamines,/Intermediates / Sides Products ”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/079321
“Methods for Prod. of Non-Natural Tryptophans, Tryptamines, Psilocybin Interm. / Derivatives”
U.S. Provisional Patent Application 63/263,616 “Prod. Non-Natural Tryptophans/Tryptamines/Psilocybin Inter.Derivatives”
U.S. Provisional Patent Application 63/263,623 “Methods for De Novo Prod. of Psilocybin/Intermediates/Side products”
U.S.PCT (Non- Provisional) Patent Application
PCT/US2022/079329
“Alternative Biosynthesis Pathways for the Production of Psilocybin and Intermediates or Side products”
U.S. Provisional Patent Application 63/203,970 “Alternative Biosynthesis Pathways for Psilocybin/Intermediates/Side products”